{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:17:36Z","timestamp":1787865456434,"version":"build-2784847793"},"reference-count":65,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.contraception.2011.04.009","type":"journal-article","created":{"date-parts":[[2011,6,19]],"date-time":"2011-06-19T15:21:02Z","timestamp":1308496862000},"page":"549-557","source":"Crossref","is-referenced-by-count":41,"title":["Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide"],"prefix":"10.1016","volume":"84","author":[{"given":"Jan","family":"Endrikat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Gerlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"D\u00fcsterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2011.04.009_bb0005","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0010-7824(93)90025-3","article-title":"Ultrasound evaluation of ovarian activity under oral contraceptives","volume":"47","author":"Hoogland","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.04.009_bb0010","unstructured":"Tortora GJ, Grabowski SR. Principes d'anatomie et de physiologie. Centre \u00e9ducatif et culturel (Anjou);1994:1204 pages."},{"key":"10.1016\/j.contraception.2011.04.009_bb0015","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1080\/13625180400007736","article-title":"Clinical profile of contraceptive progestins","volume":"9","author":"Benagiano","year":"2004","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2011.04.009_bb0020","series-title":"Generalized linear models","author":"McCullagh","year":"1989"},{"key":"10.1016\/j.contraception.2011.04.009_bb0025","unstructured":"www.SAS.com (accessed on 2009-07-20)."},{"key":"10.1016\/j.contraception.2011.04.009_bb0030","first-page":"57","article-title":"Inhibition of ovulation determined by estimation of pregnanediol excretion","volume":"9","author":"Nevinny-Stickel","year":"1964","journal-title":"Int J Fertil"},{"key":"10.1016\/j.contraception.2011.04.009_bb0035","first-page":"467","article-title":"Comparative study of urinary excretion of steroids following administration of chlormadinone, ethinyl estradiol, methyl ether of ethinyl estradiol or norethindrone. Attempt at explanation of the mechanism of action of these various bodies","volume":"64","author":"Gueguen","year":"1965","journal-title":"Gynecol Obstet (Paris)"},{"key":"10.1016\/j.contraception.2011.04.009_bb0040","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0015-0282(16)35522-4","article-title":"The role of progestogens in the hormonal control of fertility","volume":"16","author":"Rudel","year":"1965","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2011.04.009_bb0045","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0015-0282(16)39850-8","article-title":"Effect of mini-pills on physiologic responses of human cervical mucus, endometrium and ovary","volume":"24","author":"Aref","year":"1973","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2011.04.009_bb0050","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1530\/acta.0.0620679","article-title":"Pituitary and ovarian function in women on continuous low dose progestogens; effects of chlormadinone acetate and norethisterone","volume":"62","author":"Diczfalusy","year":"1969","journal-title":"Acta Endocr (Kbh)"},{"key":"10.1016\/j.contraception.2011.04.009_bb0055","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/0002-9378(68)90463-8","article-title":"Presence of corpus luteum as evidence of ovulation in women treated with low dose of chlormadinone acetate","volume":"102","author":"Guti\u00e9rrez-Najar","year":"1968","journal-title":"Am J Obstet Gynec"},{"key":"10.1016\/j.contraception.2011.04.009_bb0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0010-7824(71)90040-0","article-title":"Hormonal contraception with 0.5 mg chlormadinone acetate by continuous administration","volume":"3","author":"Heinen","year":"1971","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.04.009_bb0065","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/acta.0.0630705","article-title":"Effects of continuous daily administration of 0.5 mg of chlormadinone acetate on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone and total oestrogens","volume":"63","author":"Larsson-Cohn","year":"1970","journal-title":"Acta Endocr"},{"key":"10.1016\/j.contraception.2011.04.009_bb0070","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1471-0528.1968.tb02895.x","article-title":"Chlormadinone acetate as an oral contraceptive: clinical results and the incidence of ovulation","volume":"75","author":"MacDonald","year":"1968","journal-title":"J Obstet Gynaec Brit Cwlth"},{"key":"10.1016\/j.contraception.2011.04.009_bb0075","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0015-0282(16)35825-3","article-title":"Low doses of progestogen as an approach to fertility control","volume":"17","author":"Martinez-Manautou","year":"1966","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2011.04.009_bb0080","first-page":"79","article-title":"Administration prolong\u00e9e d'ac\u00e9tate de chlormadinone. Effets m\u00e9taboliques, tensionnels et hormonaux","volume":"42","author":"P\u00e9lissier","year":"1991","journal-title":"Gyn\u00e9cologie"},{"key":"10.1016\/j.contraception.2011.04.009_bb0085","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0015-0282(16)38227-9","article-title":"Effect of daily administration of 0.5 mg of chlormadinone acetate on plasma levels of follicle-stimulating hormone, luteinizing hormone and progesterone during the menstrual cycle","volume":"22","author":"Saunders","year":"1971","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2011.04.009_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0015-0282(16)37980-8","article-title":"Levels of serum follicle-stimulating hormone, luteinizing hormone, and plasma progestin during microdose chlormadinone treatment","volume":"22","author":"Taymor","year":"1971","journal-title":"Fertil Steril"},{"issue":"suppl","key":"10.1016\/j.contraception.2011.04.009_bb0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/00016347909157223","article-title":"Ovulation inhibition with different doses of levonorgestrel and other progestogens: clinical and experimental investigations","volume":"88","author":"Spona","year":"1979","journal-title":"Acta Obtet Gyecol Scand"},{"key":"10.1016\/j.contraception.2011.04.009_bb0100","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000298860","article-title":"Efficacy of low-dose oral contraceptives containing levonorgestrel, gestodene and cyproterone acetate","volume":"23","author":"Spona","year":"1987","journal-title":"Gynecol Obstet Invest"},{"issue":"suppl","key":"10.1016\/j.contraception.2011.04.009_bb0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/00016348209155355","article-title":"Central and peripheral effects of desogestrel 15\u201360 mcg daily for 21 days in healthy female volunteers","volume":"111","author":"Cullberg","year":"1982","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2011.04.009_bb0110","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0010-7824(92)90099-F","article-title":"Influence of oral contraceptives on integrated secretion of gonadotropins","volume":"46","author":"Dericks-Tan","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.04.009_bb0115","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/01443619409027851","article-title":"A study comparing the ovarian effects of levonorgestrel and desogestrel given orally and by vaginal ring","volume":"14","author":"Jackson","year":"1994","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2011.04.009_bb0120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0015-0282(01)01824-6","article-title":"Ovarian function during and after treatment with the new progestagen Org 30659","volume":"76","author":"Obruca","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2011.04.009_bb0125","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0010-7824(76)90004-4","article-title":"The influence on the pituitary\u2013ovarian function, cervical mucus and vaginal cytology of a new progestational compound","volume":"14","author":"Skouby","year":"1976","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.04.009_bb0130","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1530\/acta.0.0830429","article-title":"Biological effects of a new and potent progestogen. A clinical study","volume":"83","author":"Viinikka","year":"1976","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.contraception.2011.04.009_bb0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0010-7824(77)90129-9","article-title":"Ovulation inhibition by a new low-dose progestagen","volume":"16","author":"Viinikka","year":"1977","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.04.009_bb0140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2165\/00044011-199918040-00003","article-title":"Influence of dinogest on ovulation in young fertile women","volume":"18","author":"Moore","year":"1999","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.contraception.2011.04.009_bb0145","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/13625180008500376","article-title":"Inhibition of ovulation by a novel progestogen (drospirenone) alone or in combination with ethinylestradiol","volume":"5","author":"Rosenbaum","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2011.04.009_bb0150","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF01982941","article-title":"Inhibition of ovulation by a triphasic gestodene-containing oral contraceptive","volume":"9","author":"Spona","year":"1993","journal-title":"Adv Contracept"},{"key":"10.1016\/j.contraception.2011.04.009_bb0155","first-page":"11","article-title":"Small-scale clinical trials of progestogens for control of contraception","volume":"9","author":"Swyer","year":"1964","journal-title":"Int J Fertil"},{"key":"10.1016\/j.contraception.2011.04.009_bb0160","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/acta.0.0400203","article-title":"Effect of dydrogesterone on human endometrium and ovarian activity","volume":"40","author":"Bishop","year":"1962","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/j.contraception.2011.04.009_bb0165","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/humrep\/14.4.982","article-title":"A comparison of the inhibition of ovulation achieved by desogestrel 75 mcg and levonorgestrel 30 mcg daily","volume":"14","author":"Rice","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2011.04.009_bb0170","first-page":"73","article-title":"\u00c9volution des gonadotrophines hypophysaires et des stero\u00efdes ovariens sous l'effet d'un traitement progestatif pris \u00e0 partir de 10e jour du cycle (Lynestrenol 10 mg\/jour)","volume":"29","author":"Dargent","year":"1978","journal-title":"Gyn\u00e9cologie"},{"key":"10.1016\/j.contraception.2011.04.009_bb0175","first-page":"246","article-title":"Clinical trial and laboratory investigation of a low-dose progestogen-only contraceptive\u2014Exluton","volume":"18","author":"Foley","year":"1973","journal-title":"Int J Fert"},{"key":"10.1016\/j.contraception.2011.04.009_bb0180","first-page":"1277","article-title":"The effect of 0.5 mg lynestrenol on the follicle stimulating hormone, luteinizing hormone, oestrogen and pregnanediol excretion during the menstrual cycle","volume":"19","author":"Schmidt-Elmendorff","year":"1969","journal-title":"Arzneimittel-Forsch"},{"key":"10.1016\/j.contraception.2011.04.009_bb0185","first-page":"705","article-title":"Inhibition de l'ovulation par la m\u00e9drogestone administr\u00e9e du 4e au 24e jour du cycle","volume":"22","author":"Strauch","year":"1994","journal-title":"Fertil Contracept Sexual"},{"key":"10.1016\/j.contraception.2011.04.009_bb0190","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9378(63)90427-7","article-title":"Clinical uses of 17\u03b1-hydroxy-6\u03b1-methylprogesterone","volume":"86","author":"Eichner","year":"1963","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.04.009_bb0195","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0028-2243(90)90015-S","article-title":"Inhibition of ovulation with oral progestins\u2014effectiveness in premenstrual syndrome","volume":"34","author":"West","year":"1990","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2011.04.009_bb0200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/00016348409154654","article-title":"The plasma concentration of medroxyprogesterone acetate and ovarian function during treatment with medroxyprogesterone acetate in 5 and 10 mg doses","volume":"63","author":"Wikstr\u00f6m","year":"1984","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2011.04.009_bb0205","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1471-0528.1987.tb02322.x","article-title":"Effect of nomegestrol acetate, a new 19-nor-progesterone derivative, on pituitary\u2013ovarian function in women","volume":"94","author":"Bazin","year":"1987","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2011.04.009_bb0210","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1210\/jc.84.11.4191","article-title":"The antigonadotrophic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women","volume":"84","author":"Couzinet","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2011.04.009_bb0215","first-page":"431","article-title":"The effect of 17alpha-ethinyl-19-nortestosterone (norethisterone) on the urinary excretion of oestrogens, pregnanediol and gonadotrophins during the menstrual cycle","volume":"53","author":"Brown","year":"1960","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.contraception.2011.04.009_bb0220","first-page":"231","article-title":"The influence of gestagens on the urinary excretion of pituitary gonadotropins, estrogens, and pregnanediol in women in the post-menopause and during the menstrual cycle","volume":"9","author":"Buchholz","year":"1964","journal-title":"Int J Fert"},{"key":"10.1016\/j.contraception.2011.04.009_bb0225","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0020-7292(95)02610-X","article-title":"Ultrasonographic monitoring of ovarian follicles in women using norethisterone for contraception","volume":"53","author":"Chitlange","year":"1996","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2011.04.009_bb0230","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1471-0528.1976.tb00801.x","article-title":"The effects of daily norethisterone (0.35 mg) on cervical mucus and on urinary LH, pregnanediol and oestrogen levels","volume":"83","author":"Elstein","year":"1976","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.contraception.2011.04.009_bb0235","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0010-7824(92)90141-F","article-title":"Is the contraceptive effect of 300 mcg of norethisterone mainly peripheral or central?","volume":"45","author":"Kim-Bj\u00f6rklund","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.04.009_bb0240","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/acta.0.0710551","article-title":"Effects of continuous daily administration of 0.1 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone and total oestrogens","volume":"71","author":"Larsson-Cohn","year":"1972","journal-title":"Acta Endocr"},{"key":"10.1016\/j.contraception.2011.04.009_bb0245","first-page":"585","article-title":"Contraceptive mechanism of microdose norethindrone","volume":"41","author":"Moghissi","year":"1972","journal-title":"Obstet Gynecol"},{"issue":"Suppl 28","key":"10.1016\/j.contraception.2011.04.009_bb0250","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1530\/acta.0.023S018","article-title":"Some effects of progesterone and related compounds upon reproduction and early development in mamals","volume":"23","author":"Pincus","year":"1956","journal-title":"Acta Endocrinol"},{"key":"10.1016\/j.contraception.2011.04.009_bb0255","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(64)90620-8","article-title":"Ovarian function during and after long-term treatment with ovulation inhibitors","volume":"14","author":"Shearman","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2011.04.009_bb0260","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0002-9378(16)35792-1","article-title":"Laboratory and clinical effects of nortestosterone. III. Ovulation-inhibiting effects of small dosages of 17 alpha-19-nortestosterone acetate","volume":"84","author":"Taymor","year":"1962","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.04.009_bb0265","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1677\/joe.0.0250331","article-title":"The effect of norethisterone and its acetate on ovarian and pituitary function during the menstrual cycle","volume":"25","author":"Brown","year":"1962","journal-title":"J Endocr"},{"key":"10.1016\/j.contraception.2011.04.009_bb0270","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0002-9378(58)90555-6","article-title":"Effects of three 19-norsteroids on human ovulation and menstruation","volume":"75","author":"Garcia","year":"1958","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.04.009_bb0275","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1530\/acta.0.0570536","article-title":"Urinary FSH and LH excretion following combined treatment with norethisterone acetate and ethinyl estradiol and norethisterone acetate only","volume":"57","author":"McCormick","year":"1968","journal-title":"Acta Endocr"},{"key":"10.1016\/j.contraception.2011.04.009_bb0280","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1210\/jcem-24-8-803","article-title":"Effect of synthetic progestins on pituitary gonadotrophin excretion","volume":"24","author":"Taymor","year":"1964","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2011.04.009_bb0285","first-page":"193","article-title":"Doses-related effects of lynestrenol on ovulation","volume":"3","author":"Pizzaro","year":"1976","journal-title":"Reproduccion"},{"key":"10.1016\/j.contraception.2011.04.009_bb0290","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/bmj.4.5629.489","article-title":"Contraceptive action of continuous low doses of norgestrel","volume":"4","author":"Foss","year":"1968","journal-title":"Br Med J"},{"key":"10.1016\/j.contraception.2011.04.009_bb0295","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0015-0282(16)38342-X","article-title":"Effects of microdose norgestrel on endogenous gonadotropic and steroid hormones, cervical mucus properties, vaginal cytology, and endometrium","volume":"22","author":"Moghissi","year":"1971","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2011.04.009_bb0300","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1471-0528.1970.tb03409.x","article-title":"Effect of daily small doses of nogestrel on ovarian function","volume":"77","author":"Wright","year":"1970","journal-title":"J Obstet Gynaecol Br Cwlth"},{"key":"10.1016\/j.contraception.2011.04.009_bb0305","first-page":"47","article-title":"Utilisation d'un progestatif du groupe 19-norprogest\u00e9rone comme inhibiteur de l'ovulation","volume":"1","author":"Rosenbaum","year":"1984","journal-title":"Horm Reprod Metab"},{"key":"10.1016\/j.contraception.2011.04.009_bb0310","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0015-0282(16)41298-7","article-title":"Studies on the mechanism of action of continuous microdose quingestanol acetate","volume":"26","author":"Moghissi","year":"1975","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2011.04.009_bb0315","first-page":"61","article-title":"Ovulation-inhibiting properties of OD 14","volume":"6","author":"Franchimont","year":"1982","journal-title":"Reproduccion"},{"issue":"2a","key":"10.1016\/j.contraception.2011.04.009_bb0320","first-page":"296","article-title":"Probleme der Dosifindung: Sexualhormone","volume":"27","author":"Neumann","year":"1977","journal-title":"Drug Res"},{"key":"10.1016\/j.contraception.2011.04.009_bb0325","series-title":"Gestodene, a new direction in oral contraception (chap 1: 13\u201329)","article-title":"Pharmacological features of gestodene in laboratory animals and man","author":"D\u00fcsterberg","year":"1988"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411001740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411001740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:44:00Z","timestamp":1560300240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782411001740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":65,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0010782411001740"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2011.04.009","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}